Available online 21 September 2022

Chronic rhinitis encompassing both allergic and non-allergic rhinitis affects a significant portion of the population worldwide, having a great impact on patient quality of life, and associated co-morbid conditions, with an important societal economic burden. Allergists are often the first to evaluate and treat allergic and non-allergic rhinitis, addressing the individual triggers of the disease as well as the patient specific responses to these triggers. This review focuses on the advances that have been made in the diagnosis, management and treatment of non-allergic and allergic rhinitis over the past 10 years, including specific allergen immunotherapy, care pathways and digital health.

© 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology